WallStSmart
AKTS

Aktis Oncology, Inc. Common stock

NASDAQ: AKTS · HEALTHCARE · BIOTECHNOLOGY

$16.82
+2.25% today

Updated 2026-10-28

Market cap
$837.63M
P/E ratio
—
P/S ratio
83.26x
EPS (TTM)
$-1.70
Dividend yield
—
52W range
$15 – $34
Volume
0.4M

Aktis Oncology, Inc. Common stock (AKTS) Insider transactions

Net insider activity
Net buying (3,295,238 shares)
Buy transactions
47
Sell transactions
53

All transactions

DateInsiderTitleTypeSharesPriceValue
2024-01-29SHEALY, JEFFREY B.Director, Chief Executive OfficerBuy1,310,000$0.50$655000.00
2024-01-29GEISS, ARTHURDirectorBuy50,000$0.50$25000.00
2024-01-29BOLLER, KENNETHCFOBuy60,000$0.50$30000.00
2024-01-29AICHELE, DAVIDEVP of Business DevelopmentBuy80,000$0.50$40000.00
2023-12-18BOLLER, KENNETHCFOSale1,200$0.72$864.72
2023-12-18AICHELE, DAVIDEVP of Business DevelopmentSale1,500$0.72$1083.00
2023-11-21BOLLER, KENNETHCFOSale1,700$0.59$1001.30
2023-11-21AICHELE, DAVIDEVP of Business DevelopmentSale2,600$0.59$1534.78
2023-11-06RUDY, SUZANNE BDirectorBuy108,250——
2023-11-06PETOCK, MICHELLEDirectorBuy185,000——
2023-11-06NEAL, JERRY DDirectorBuy125,750——
2023-11-06MCMAHON, JEFFREYDirectorBuy78,250——
2023-11-06MCGUIRE, JAMES MICHAELDirectorBuy83,500——
2023-11-06GEISS, ARTHURDirectorBuy138,333——
2023-11-06DENBAARS, STEVENDirectorBuy76,500——
2023-11-06DENBAARS, STEVENDirectorBuy38,250——
2023-09-26SHEALY, JEFFREY B.Director, Chief Executive OfficerBuy80,000——
2023-09-13BOLLER, KENNETHCFOBuy40,000——
2023-09-13AICHELE, DAVIDEVP of Business DevelopmentBuy40,000——
2023-09-11BOLLER, KENNETHCFOSale3,900$1.10$4290.00
2023-09-11AICHELE, DAVIDEVP of Business DevelopmentSale5,300$1.09$5777.00
2023-08-18DENBAARS, STEVENDirectorSale7,000$1.83$12810.00
2023-03-23PETOCK, MICHELLEDirectorBuy24,151——
2023-03-09MCGUIRE, JAMES MICHAELDirectorBuy2,002——
2023-02-10BOLLER, KENNETHCFOSale800$4.37$3496.00
2023-01-24SHEALY, JEFFREY B.Director, Chief Executive OfficerBuy327,273$2.75$900000.75
2023-01-24DENBAARS, STEVENDirectorBuy18,182$2.75$50000.50
2022-12-20SHEALY, JEFFREY B.Director, Chief Executive OfficerSale2,340$2.84$6645.60
2022-12-19BOLLER, KENNETHCFOSale1,200$2.92$3504.00
2022-12-19AICHELE, DAVIDEVP of Business DevelopmentSale1,480$3.14$4647.20
2022-12-06DENBAARS, STEVENDirectorSale7,000$3.57$24990.00
2022-11-28SHEALY, JEFFREY B.Director, Chief Executive OfficerSale1,950$3.54$6903.00
2022-11-23BOLLER, KENNETHCFOSale1,200$3.52$4224.00
2022-11-23AICHELE, DAVIDEVP of Business DevelopmentSale1,850$3.52$6512.00
2022-11-21SHEALY, JEFFREY B.Director, Chief Executive OfficerBuy50,000——
2022-11-21BOLLER, KENNETHCFOBuy25,000——
2022-11-21AICHELE, DAVIDEVP of Business DevelopmentBuy35,000——
2022-11-10RUDY, SUZANNE BDirectorBuy113,152——
2022-11-10NEAL, JERRY DDirectorBuy65,722——
2022-11-10MCMAHON, JEFFREYDirectorBuy84,146——
2022-11-10MCGUIRE, JAMES MICHAELDirectorBuy40,766——
2022-11-10GEISS, ARTHURDirectorBuy72,299——
2022-11-10DENBAARS, STEVENDirectorBuy39,982——
2022-09-09SHEALY, JEFFREY B.Director, Chief Executive OfficerSale3,900$4.30$16770.00
2022-09-06DENBAARS, STEVENDirectorSale7,000$3.90$27300.00
2022-08-29SHEALY, JEFFREY B.Director, Chief Executive OfficerSale3,900$4.54$17706.00
2022-08-29BOLLER, KENNETHCFOSale2,400$4.53$10872.00
2022-08-29AICHELE, DAVIDEVP of Business DevelopmentSale3,700$4.53$16761.00
2022-08-22BOLLER, KENNETHCFOSale1,500$4.62$6930.00
2022-08-22AICHELE, DAVIDEVP of Business DevelopmentSale1,480$4.62$6837.60
2022-07-18AICHELE, DAVIDEVP of Business DevelopmentSale2,313$3.68$8511.84
2022-06-20GEISS, ARTHURDirectorSale10,000——
2022-06-20GEISS, ARTHURDirectorBuy10,000$1.50$15000.00
2022-06-06DENBAARS, STEVENDirectorSale7,000$4.48$31360.00
2022-04-08AICHELE, DAVIDEVP of Business DevelopmentSale5,000$5.93$29650.00
2022-02-17GEISS, ARTHURDirectorSale20,000——
2022-02-17GEISS, ARTHURDirectorBuy20,000$1.50$30000.00
2022-02-14DENBAARS, STEVENDirectorSale8,013——
2022-02-14DENBAARS, STEVENDirectorBuy8,013$6.24$50001.12
2022-02-10SHEALY, JEFFREY B.Director, Chief Executive OfficerSale15,000——
2022-02-10SHEALY, JEFFREY B.Director, Chief Executive OfficerBuy15,000$7.12$106800.00
2022-02-10BOLLER, KENNETHCFOBuy15,000——
2022-02-10BOLLER, KENNETHCFOBuy10,000——
2022-02-07MCGUIRE, JAMES MICHAELDirectorBuy17,800$5.62$100036.00
2022-01-11DENBAARS, STEVENDirectorSale7,000$5.91$41370.00
2021-12-20BOLLER, KENNETHInterim CFOSale2,100$6.69$14049.00
2021-12-20AICHELE, DAVIDEVP of Business DevelopmentSale1,480$6.64$9827.20
2021-12-17SHEALY, JEFFREY B.Director, Chief Executive OfficerSale13,928$7.01$97635.28
2021-11-23BOLLER, KENNETHInterim CFOSale900$6.97$6273.00
2021-11-23AICHELE, DAVIDEVP of Business DevelopmentSale1,850$6.77$12524.50
2021-11-09RUDY, SUZANNE BDirectorSale12,731$8.11$103248.41
2021-10-29GEISS, ARTHURDirectorSale10,000$7.47$74700.00
2021-10-28RUDY, SUZANNE BDirectorBuy22,543——
2021-10-28NEAL, JERRY DDirectorBuy27,456——
2021-10-28MCMAHON, JEFFREYDirectorBuy17,576——
2021-10-28MCGUIRE, JAMES MICHAELDirectorBuy17,030——
2021-10-28GEISS, ARTHURDirectorBuy22,652——
2021-10-28DENBAARS, STEVENDirectorBuy16,703——
2021-10-11DENBAARS, STEVENDirectorSale7,000$8.08$56560.00
2021-09-27AICHELE, DAVIDEVP of Business DevelopmentSale1,388$10.60$14712.80
2021-09-09SHEALY, JEFFREY B.Director, Chief Executive OfficerBuy50,000——
2021-09-09SHEALY, JEFFREY B.Director, Chief Executive OfficerBuy50,000——
2021-08-30BOLLER, KENNETHInterim CFOSale900$10.00$9000.00
2021-08-30AICHELE, DAVIDEVP of Business DevelopmentSale1,850$9.04$16724.00
2021-08-27BOLLER, KENNETHInterim CFOBuy25,000——
2021-08-27BOLLER, KENNETHInterim CFOBuy15,000——
2021-08-27AICHELE, DAVIDEVP of Business DevelopmentBuy40,000——
2021-08-27AICHELE, DAVIDEVP of Business DevelopmentBuy25,000——
2021-08-23HOULDEN, ROHANChief Product OfficerSale880$8.15$7172.00
2021-08-20BOLLER, KENNETHInterim CFOSale1,200$8.24$9888.00
2021-08-20AICHELE, DAVIDEVP of Business DevelopmentSale1,480$8.23$12180.40
2021-07-19HOULDEN, ROHANChief Product OfficerSale1,375$8.96$12320.00
2021-07-16AICHELE, DAVIDEVP of Business DevelopmentSale2,313$9.37$21672.81
2021-07-12DENBAARS, STEVENDirectorSale7,000$9.93$69510.00
2021-04-12DENBAARS, STEVENDirectorSale7,000$12.00$84000.00
2021-04-08SHEALY, JEFFREY B.Director, Chief Executive OfficerSale100,000$12.03$1.20M
2021-04-07SHEALY, JEFFREY B.Director, Chief Executive OfficerSale100,000$12.51$1.25M
2021-03-22AICHELE, DAVIDEVP of Business DevelopmentSale5,000$13.72$68600.00
2021-03-17BOLLER, KENNETHInterim CFOSale1,442$13.99$20173.58
2021-03-16SHEALY, JEFFREY B.Director, Chief Executive OfficerSale100,000$13.32$1.33M

Frequently asked questions

Are AKTS insiders buying or selling?

Over the transactions on record, AKTS insiders have been net sellers, with about $4.81M in stock sold across 53 sales, against 11 open-market purchases.

Does insider selling at AKTS mean the stock will fall?

Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.

Which AKTS insiders are selling the most?

Recent selling is concentrated in a few names. SHEALY, JEFFREY B. accounts for the largest share on record, with about $3.93M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.